Fieldcure

Seoul, KR · 1 known investors

FieldCure develops iMET, an electric field-based cancer therapy device that applies alternating electric fields at specific frequencies to disrupt mitosis in cancer cells while sparing normal cells. The system includes 64-channel electrode control and an AI-based treatment planning system for patient-specific optimization, targeting intractable cancers such as pancreatic cancer.

AI & Machine LearningHealthtechMedical Devices